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ABSTRACT
Objectives: The objective of this research was to obtain isolates capable of producing a high yield of L-asparaginase enzyme and to evaluate the 
antitumor activity of the purified enzyme against different cancer and normal cell lines.
Methods: Isolation of bacteria was performed by the serial dilution technique of soil samples collected from Cairo, Egypt, using modified M9 agar 
plates. Culture filtrates of selected isolates were quantitatively screened for L-asparaginase production using well-diffusion and direct nesslerization 
techniques. Factors influencing L-asparaginase activity were optimized by studying the effect of physical and nutritional conditions on the enzyme 
activity. The purification of L-asparaginase extracted from both the isolates was achieved using chilled acetone (−20°C), followed by gel filtration on 
Sephadex G-100. The anticancer activity of the purified enzyme against human breast adenocarcinoma (MCF-7), human hepatocellular carcinoma 
(HepGII) and homo sapiens human (WISH) cell line was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide assay.
Results: Two L-asparaginase producers were identified by Biolog identification system as Pectobacterium carotovorum and Serratia marcescens. 
Optimization increased the production of L-asparaginase to 4.835 and 5.221 U/ml for P. carotovorum and S. marcescens, respectively. L-asparaginase 
was extracted, purified, and tested in vitro for cytotoxic activity using 3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT assay) 
against MCF-7, HepGII, and WISH cell line. L-asparaginase from P. carotovorum and S. marcescens was neutral to normal epithelial WISH cells. On the 
other hand, L-asparaginase from both isolates was cytotoxic to MCF-7 and HepGII cancer cell lines with an half maximal inhibitory concentration of 15 
μg/ml and 26 μg/ml and 26 μg/ml and 25 μg/ml, respectively.
Conclusion: L-asparaginase extracted from P. carotovorum and S. marcescens showed remarkable anticancer activity. Further studies on 
hypersensitivity action need to be carried out to recommend the use of L-asparaginase as an alternative to commercially available preparations.
Keywords: L-asparaginase, Optimization, Cytotoxicity, Pectobacterium, Serratia.
INTRODUCTION
L-asparaginase is relatively widespread enzyme found in bacteria, 
yeast, fungi, and plants. It catalyzed the hydrolysis of the amide group 
of asparagine to yield aspartate and ammonia [1]. Many reports 
demonstrated the anti-leukemic activity of L-asparaginase [2-4]. 
Today, L-asparaginase is an essential drug that is used in the treatment 
of acute lymphoblastic leukemia in children all over the world. 
ELSPAR, ONCASPAR, KIDROLASE, and ERWINASE are the brand 
name of L-asparaginase used as drug [5]. The antitumor activity of 
L-asparaginase was believed to be because most neoplastic tissues 
require their exogenous supply of L-asparagine from circulating pools 
because of the absence of L-asparagine synthetase. On the other 
hand, normal cells synthesize L-asparagine in sufficient quantities 
for protein synthesis within the cell by L-asparagine synthetase from 
aspartic acid and glutamine or can be absorb available L-asparagine 
from the cell surrounding. L-asparaginase breakdowns the circulating 
asparagine to L-aspartate and ammonia and prevents protein synthesis 
of neoplasms. Therefore, the most common therapeutic practice to treat 
this condition is to intravenously administer L-asparaginase to deplete 
the blood L-asparagine level and exhaust its supply to selectively affect 
the neoplastic cells [6].
Microbial sources are very common and convenient for L-asparaginase 
production since they can be easily cultured and produced compounds 
that could be extracted and purified, as a result facilitating the industrial 
scale production [7]. The most commonly used microorganisms to 
produce L-asparaginase were Escherichia coli, Bacillus sp., Streptomyces 
albidoflavus, and actinomycetes from the rhizosphere of medicinal 
plants [8]. L-asparaginase from E. coli and Erwinia chrysanthemi 
has a perfect action to inhibit the activity of tumor cells. They were 
clinically used as effective drugs in the treatment of Hodgkin’s 
disease, acute myelocytic leukemia, acute myelomonocytic leukemia, 
chronic lymphocytic leukemia, lymphosarcoma, reticulosarcoma, and 
melanosarcoma [9]. However, L-asparaginase from these two bacterial 
sources caused hypersensitivity in the long term leading to mild allergic 
reactions to anaphylactic shock [10]. E. chrysanthemi L-asparaginase 
exhibited less allergic reactions compared to the E. coli enzyme. 
However, Erwinia (synonym: Pectobacterium) [11,12] L-asparaginase 
had a shorter half-life than E. coli [13]. This advocated the need to 
discover new L-asparaginases with less adverse effects but has similar 
therapeutic effects. Therefore, the aim of this work was to obtain 
isolates capable of producing a high yield of L-asparaginase enzyme 
and to evaluate the antitumor activity of the purified enzyme against 
different human cell lines.
METHODS
Detection and screening L-asparaginase-producing bacteria
Isolation of bacteria was performed by the serial dilution technique 
of two soil samples collected from two sites from Cairo, Egypt, into 
sterile bottles at a depth of 30–40 cm, using modified M9 agar plates 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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containing 5 µg/ml of nystatin as an antifungal agent and supplemented 
with 0.09% phenol red (prepared in ethanol) as indicator. The pH was 
adjusted to 6.2 using 1 N HCl. M9 medium plates without both indicator 
and asparagine served as controls (instead containing NaNO3 as 
nitrogen source) were also prepared. After incubation at 37°C for 48 h, 
colonies with pink zones were considered as L-asparaginase-producing 
bacteria.
Culture filtrates of selected isolates were semi-quantitatively screened 
for L-asparaginase production using well diffusion technique. Sterile 
Erlenmeyer flasks (250 ml) containing 50 ml sterile modified asparagine 
M9 broth medium were inoculated with 1 ml (106 colony-forming unit 
[CFU]) of each isolate that showed production of L-asparaginase. Flasks 
were incubated at 37°C for 24 h in a rotatory shaking incubator at 120 
revolutions per minute (rpm) [14].
Wells (5-mm diameter) were made using sterilized cork borer in the 
center of modified M9 agar plate, and then, 50 μl of broth culture was 
transferred to each well. After incubation at 37°C for 24 h, the diameter 
of pink zones around the wells was measured and recorded [14].
Identification of bacterial isolates
The preliminary identification of potential isolates was performed 
according to Bergey’s Manual of Systematic Bacteriology [15]. 
Identification of the potent isolates was carried out by Biolog System 
(GEN III identification) EGYVAC - VACSERA, Giza, Egypt.
Assay of L-asparaginase
An overnight inoculum (1 ml) of bacterial suspension (106 CFU) was 
transferred to 250 ml Erlenmeyer flasks with 50 ml broth modified M9 
medium and incubated in a shaking incubator (120 rpm) at 37°C for 
24 h. After incubation, bacterial cells were removed by centrifugation at 
10,000 rpm for 10 min at 4°C [16]. The supernatant was used to assay 
extracellular L-asparaginase activity which was measured by Nessler’s 
reaction (Direct Nesslerization of ammonia) according to Mashburn 
and Wriston [17]. The blank was prepared by mixing distilled water 
with Nessler’s reagent. The concentration of ammonia was estimated 
and the absorbance was measured at 450 nm, using spectrophotometer 
(Thermo scientific). A standard curve was drawn with various 
concentrations of ammonia.
Optimization of L-asparaginase production
Factors influencing L-asparaginase activity were optimized by studying 
the effect of physical and nutritional conditions on the enzyme activity. 
The optimal condition identified for each parameter was applied for 
optimizing the next one.
Optimization of different environmental conditions (incubation 
temperature, pH, and incubation period) for L-asparaginase 
production
The optimum temperature for maximum L-asparaginase production 
was determined by incubating the cultures at different temperatures 
from 25 to 40°C with an interval of 5°C on M9 media for 24 h. To detect 
the optimum pH for the production of L-asparaginase, media were 
adjusted at different pH values (6.5, 7.0, 7.5, and 8.0) using 1 N NaOH/1N 
HCl. The effect of incubation period on L-asparaginase production by 
the bacterial cultures was determined by incubating for 24, 48, 72, and 
120 h. For each parameter, bacterial isolates were grown on M9 broth 
medium and the cultures supernatants were assayed as described 
(2.3) [18]. The optimal condition identified for each parameter was 
applied for optimizing the next one.
Optimization of different nutritional factors (carbon and nitrogen 
sources) for L-asparaginase production
The addition of different carbon and nitrogen sources other than 
glucose and L-asparagine was made separately in the medium, to 
enhance enzyme production such as sucrose, maltose, and lactose and 
yeast extract, peptone, and ammonium nitrate at 1% (w/v) according 
to Indira et al. [19].
Purification of L-asparaginase
The culture filtrate was filtered through Whatman No. 1 filter paper 
(0.22 µ) and centrifuged at 8000 rpm for 10 min at 4°C. Chilled acetone 
(−20°C) was added to the culture filtrate (crude enzyme) with constant 
stirring at 4°C in the gradient concentration of 4:1, for proteins to 
precipitate. The precipitated proteins were centrifuged and air dried 
then dissolved in 0.01 M phosphate buffer (pH 8.5).
The concentrated enzyme was applied to diethylaminoethyl cellulose 
column (4 cm × 60 cm) equilibrated with 50 mM Tris-HCl (pH-8.6). The 
column was washed with two volumes of starting buffer, and the protein 
was eluted with linear gradient of NaCl (0–0.5 M) prepared in phosphate 
buffer pH 7.4 at the rate of 60 ml/h. Fractions showing L-asparaginase 
activity were pooled together dialyzed against 50 mM Tris-HCl (pH8.6) 
and concentrated with bench top protein concentrator at 4°C.
The concentrated enzyme solution was added on the top of Sephadex 
G-100 column (4 m × 60 cm) equilibrated with 50 mM Tris-HCl (pH8.6) 
and eluted with the same buffer at the flow rate of 0.5 ml/min. Fractions 
showing L-asparaginase activity were pooled and dialyzed against the 
same buffer and lyophilized with bench top lyophilizer [20].
Determination of the molecular weight of the purified enzyme 
by sodium dodecyl sulfate polyacrylamide gel electrophoreses 
(SDS-PAGE)
The molecular weight of the extracted enzyme was determined by 
performing SDS-PAGE according to the method of Laemmli [21], using 
protein marker of 10–260 KDa (Thermo Fischer Scientific).
Cytotoxicity assay
Cell lines
Three cell lines: Human breast adenocarcinoma (MCF-7; ATCC number: 
HTB-22), human hepatocellular carcinoma (HepGII; ATCC number: 
HB-8065), and Homo sapiens human (WISH, HeLa contaminant; ATCC 
number: CCL-25) were obtained from EGYVAC-VACSERA, Giza, Egypt.
Cell viability determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5 
diphenyl tetrazolium bromide (MTT) method
Each of the three cell lines, MCF-7, HepGII, and WISH, were seeded at 
2×104 cells/well in tissue culture plates and incubated at 37°C for 24 h. 
For background absorption, some wells were remained cell free as blank 
control. The L-asparaginase was added to the cells at serial concentrations 
of 100, 50, 25, 12.5, and 6.25 μg/ml, and the control was also included 
(without L-asparaginase). The final volume was adjusted to 100 μl/well. 
The plates were incubated overnight at 37°C, 5% CO2. 25 μl of (0.5 mg/
ml) MTT stain was added to each well, and the plates were incubated 
at 37°C for 4 h. 100 μl of dimethyl sulfoxide (DMSO) stop solution was 
added to each well. The plates were shaken at room temperature for 
30 min–1 h. The plates were then read using ELISA Microplate reader at 
570 nm. The percentage of viable cells was calculated from the formula:
Survival fraction=OD of treatment cell/OD of control cell.
The half maximal inhibitory concentration (IC50) was calculated by fitting 
the survival curve using GraphPad Prism software in corporate [22].
Morphological characteristics of cell lines
MCF-7 and HepGII cells were cultured in 6-well plates. L-asparaginase 
extracted from the selected isolates was added for medium at a 
concentration of IC50 (15 μg/ml and 26 μg/ml and 26 μg/ml and 25 μg/ml, 
respectively). After treatment, all the cultures were incubated at 37°C, 
5% CO2 for 24 h, then were washed well with phosphate buffered saline, 
and fixed in 10% neutral formalin for 24 h. Photographs were taken 
under an inverted Leica fluorescence 40 × 10 microscope [23].
Statistical analysis
All statistical analyses in this study were carried out using Microsoft 
Excel 2000, Analysis Tool pack (Microsoft Corporation). All data were 
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calculated from at least 3 replicates, and the standard error for each 
datum was plotted on the graph.
RESULTS AND DISCUSSION
Selection and identification of potent L-asparaginase-producing 
bacteria
Fifty-three colonies randomly selected were purified and subcultured 
on modified M9 agar media supplemented with 0.09% phenol red to 
confirm their production of L-asparaginase. Only nine isolates which 
showed pink color around the colonies confirming their production 
of L-asparaginase were selected. The ability of the production of 
L-asparaginase was based on the color change due to a change in pH 
of the medium. Asparaginase causes the hydrolysis of L-asparaginase 
into L-aspartic acid and ammonia. The release of ammonia changes pH 
due to phenol red indicator; it has a pale yellow color with the acidic 
condition, as the pH changes to alkaline it turns to pink [24]. According 
to well diffusion agar assay, two bacterial isolates, FS-4 and GS-7, that 
showed larger zone of pink color (5.2 cm±0.005 and 4.5 cm±0.005, 
respectively) were selected (Fig. 1). Similar diameters were recorded 
by Upadhyay et al. [25]. Smaller diameter in the range of 1.9 cm, 1.0 cm, 
and 0.8 cm was reported by Jain et al. [26] and Patil and Jadhav [27].
The two isolates FS-4 and GS-7 were identified using the Biolog 
identification System as Pectobacterium carotovorum and Serratia 
marcescens, respectively.
Production of L-asparaginase by P. carotovorum and S. marcescens 
isolates
P. carotovorum and S. marcescens were used to produce L-asparaginase 
enzyme on modified M9 broth media. The enzyme activities were 
4.497 U/ml±0.009 and 4.238 U/ml±0.007, while the specific activities 
were found to be 6.424 U/ml and 8.476 U/ml for P. carotovorum and 
S. marcescens, respectively.
Effect of incubation temperature on L-asparaginase production
The bacterial isolates were incubated at four different temperatures 
(25, 30, 35, and 40°C). The results showed thst the best incubation 
temperature was 35°C for P. carotovorum and 30°C for S. marcescens 
which gave activity 4.494 U/ml±0.09 and 4.503 U/ml±0.09, respectively, 
as shown in Fig. 2. Similar temperature range was reported by previous 
studies carried out by Jha et al. [28] who reported that 37°C was the 
optimal temperature for maximum activity by Pseudomonas fluorescens. 
Prakasham et al. [29] and Ghosh et al. [30] produced L-asparaginase 
at 30°C by S. marcerens and Staphylococcus sp., respectively, Similarly, 
Manna et al. [31] isolated L-asparaginase from Pseudomonas stutzeri 
under the same temperature. Temperature is a critical factor which 
has to be controlled and has to be optimized. Previous studies have 
validated that the enzyme metabolism of microorganisms represented 
an important pathway for survival and in turn depends on the 
incubation temperature [32].
Effect of initial pH on L-asparaginase production
Four initial medium pH values (6.5, 7.0, 7.5, and 8.0) were used to increase 
the L-asparaginase production by P. carotovorum and S. marcescens isolates. 
The results indicated that the P. carotovorum and S. marcescens isolates 
preferred the neutral pH value 7 and 7.5 and gave an activity of 4.497 U/
ml±0.08 and 4.443 U/ml±0.04, respectively (Fig. 3). This result is similar 
to that obtained by Narayana et al. [33] for maximum L-asparaginase 
production from S. albidoflavus at pH 7.0. Kumar et al. [34] also reported 
maximum L-asparaginase production from S. marcescens at pH 7.5. On the 
other hand, Akilandeswari et al. [35] and Neelima et al. [36] found that the 
maximum L-asparaginase production from Streptomyces ginsengisoli was 
at pH 9.0.
Effect of incubation period on L-asparaginase production
The bacterial isolates were incubated at four different periods (24, 48, 
72, and 120 h). The results showed that the best incubation period was 
48 h for both P. carotovorum and S. marcescens which gave activity 4.44 
U/ml±0.05 and 4.49 U/ml±0.04, respectively (Fig. 4). These findings 
were comparable to that described by Kumar et al. [34] who reported 
that the maximum L-asparaginase activity was observed at 48 h. After 
48 h, it was decreased due to the depletion of nutrient materials.
Effect of carbon sources on L-asparaginase production
Four carbon sources, namely glucose, sucrose, maltose, and 
lactose, were applied to enhance the L-asparaginase production by 
P. carotovorum and S. marcescens isolates. The results concluded that 
the lactose was the best carbon source for L-asparaginase production 
by P. carotovorum (4.802 U/ml±0.03), while the sucrose sugar was the 
best one for S. marcescens (5.00 U/ml±0.06) (Fig. 5). Stanbury et al. [37] 
Fig. 1: Field study-4 isolate showed highest L-asparaginase 
production
Fig. 2: L-asparaginase production by Pectobacterium carotovorum 
and Serratia marcescens isolates under different incubation 
temperatures
Fig. 3: L-asparaginase production by Pectobacterium carotovorum 
and Serratia marcescens isolates under different pH values
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stated that carbohydrates are used as carbon sources in the microbial 
fermentation processes. Kumar et al. [34] observed higher titers of 
L-asparaginase by S. marcescens when the medium was supplemented 
with 1.5% sucrose. Susmita and Mandal [38] reported sucrose as the 
best carbon source for L-asparaginase production. This may be due 
to the inductive effect of sucrose and its efficiency in asparaginase 
production, and it also helps in stabilizing the enzyme [39]. In contrary, 
El Shobaky et al. [40] indicated that the maximum L-asparaginase 
production was recorded in the presence of lactose as carbon source 
followed by maltose and fructose than sucrose. Lactose was reported 
as the best carbon source under aerobic conditions for the synthesis of 
L-asparaginase by Staphylococcus sp. [29]. However, Varalakshmi [41] 
reported a decline in L-asparaginase production on supplementation 
with fructose and a highest L-asparaginase activity by Staphylococcus 
sp. when supplemented with maltose.
Effect of nitrogen sources on L-asparaginase production
In this study, asparagine as the main nitrogen source was changed 
by yeast extract, ammonium nitrate, and peptone to enhance the 
L-asparaginase production by P. carotovorum and S. marcescens isolates. 
The results showed that the best nitrogen source was ammonium nitrate 
for P. carotovorum (4.839 U/ml±0.03) and asparagine for S. marcescens 
(4.238 U/ml±0.03) (Fig. 6). Our results agreed with El Shobaky 
et al. [40] who showed that ammonium nitrate was the most suitable 
nitrogen source for optimum L-asparaginase production followed by 
urea and sodium nitrate. Maximal production of L-asparaginase varied 
by varying the nitrogen source. Athira et al. [42] indicated sodium 
nitrate as best nitrogen source. However, Narayana et al. [33] indicated 
yeast extract to be best nitrogen source and Neelima et al. [36] used 
peptone as the best nitrogen source.
Production of L-asparaginase by P. carotovorum and S. marcescens 
isolates under optimum conditions
Optimization of conditions yields an increase in the production 
of L-asparaginase enzyme of 7.5% (from 4.497 U/ml to 4.835 U/
ml) by P. carotovorum and 23% (from 4.238 U/ml to 5.221 U/ml) by 
S. marcescens, and the specific activity was reached to 6.9 and 10.4 U/ml 
with P. carotovorum and S. marcescens, respectively (Fig. 7).
Isolation and purification of L-asparaginase enzyme
L-asparaginase enzyme produced by P. carotovorum and S. 
marcescens isolates under optimum conditions was isolated from 
free cells supernatants by precipitation. After purification, the 
molecular weight and purity of the L-asparaginase enzyme was 
assessed by running through electrophoresis SDS-PAGE. The 
purified L-asparaginase enzyme had a molecular weight of 35 kDa 
for P. carotovorum and 36 kDa for S. marcescens isolates (Fig. 8). 
L-asparaginase from different sources showed close molecular 
weights: Mohamed [43] reported that the molecular weight of 
L-asparaginase from E. coli was 33 kDa. Prista and Kyridio [44] 
indicated that E. coli L-asparaginase had molecular weight value 
33 kDa. On the other hand, Jain et al. [26] found that the molecular 
weight of purified L-asparaginase obtained from E. coli VRY-15 was 
56 KDa which was different from that of commercially available 
L-asparaginase having a molecular weight of 31.73 KDa.
In vitro cytotoxicity assay of P. carotovorum and S. marcescens 
produced L-asparaginase on MCF-7, HepGII, and WISH cell lines
Cell viability determined by MTT assay
Cell viability results of L-asparaginase enzyme obtained from 
P. carotovorum and S. marcescens isolates are summarized in Tables 1 
and 2. Cell viability of WISH cell line treated with L-asparaginase 
extracted from both isolates increased by the increase of enzyme 
concentration. No cytotoxic effect was observed for normal epithelial 
WISH cell line when treated with purified L-asparaginase. Bhat and 
Marar [45] reported that the purified enzyme did not exhibit any effect 
on normal human lymphocytes, implying that it may prove to be a novel 
source for L-asparaginase isolated for chemotherapeutic purpose.
The incubation of MCF-7 cell line with the increasing concentration 
of L-asparaginase enzyme caused a gradual inhibition of cell growth 
as observed from its low IC50 value 15 μg/ml and 26 μg/ml with 
L-asparaginase from P. carotovorum and S. marcescens, respectively. 
However, the L-asparaginase purified from S. marcescens isolate showed 
better toxicity on HepGII cell line (7.53% survival) in comparison to 
L-asparaginase produced by P. carotovorum isolate (29.81% survival). 
The sensitivity of the cell line to both L-asparaginases (purified from 
both the isolates) appeared to be dose dependent, resulting in the 
significant decrease in viable cells.
Similarly, it was reported that the purified L-asparaginase from Erwinia 
caratovora significantly increased the number of apoptotic cells to 
40% (Jurkat cells) and 99% (HL60 cells), suggesting that the enzyme 
Fig. 6: L-asparaginase production by Pectobacterium carotovorum 
and Serratia marcescens isolates under different nitrogen sources
Fig. 5: L-asparaginase production by Pectobacterium carotovorum 
and Serratia marcescens strains under different carbon sources
Fig. 4: L-asparaginase production by Pectobacterium carotovorum 
and Serratia marcescens isolates under different incubation 
periods
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cytotoxicity is associated with only L-asparagine deficiency [46]. 
L-asparaginase enzyme was tested against three different cell lines for 
its anticancerous activity, human cancer colon Caco-2, human breast 
cancer MCF-7, and human cancer prostate pc-3. The enzyme showed 
anticancer activity against MCF-7and pc-3, where it was non-effective 
to the cell line Caco-2 [43].
Morphological changes of MCF-7, HepGII, and WISH cell lines 
induced by L-asparaginase
The effect of L-asparaginase extracted from S. marcescens and 
P. carotovorum was evaluated on MCF-7, HepGII, and WISH cell 
morphology using the calculated IC50 values previously reported. The 
morphological changes were observed using inverted phase-contrast 
microscopy. The control MCF-7, HepGII, and WISH cells (treated only 
with DMSO) showed the normal morphology of cobblestone-like 
appearance with strong cell-cell adhesion, monotonous spindle-
shaped cells containing single round nuclei with flattened cytoplasm, 
and epithelioid amnion cells that grow in a closely apposed monolayer, 
respectively (Fig. 9a,d and g).
Results demonstrated that both MCF-7 and HepGII cells treated with 
L-asparaginase extracted from S. marcescens and P. carotovorum showed 
shrinkages, dispersing, and irregularity in shape, rounding cells, and 
complete detachments of cells from the surface and loss of cytoplasmic 
vacuole (Fig. 9b,c,e and f), while WISH cell have no morphological 
changes induced by L-asparaginase extracted from both P. carotovorum 
and S. marcescens isolates (Fig. 9h and i).
AUTHORS’ CONTRIBUTIONS
The majority of the experimental work was performed by Noha 
E. Abdel-Razik. All authors contributed equally to conduct this work, 
idea, protocol, consultancy, writing, and review the article.
Table 1: Efficacy of P. carotovorum L-asparaginase on cell 
viability relative to its concentration
Concentration 
(µg/ml)
% of cell viability after the application of 
P. carotovorum L-asparaginase
MCF-7 HepGII WISH
0 100±0.008 100±0.002 100±0.002
6.25 82.253±0.005 58.201±0.030 100.301±0.001
12.5 55.310±0.009 56.790±0.007 98.979±0.002
25 32.124±0.005 51.146±0.025 96.396±0.004
50 31.735±0.001 32.275±0.001 90.090±0.001
100 26.683±0.004 29.806±0.001 80.829±0.005
IC50 15 μg/ml 26 μg/ml 100 μg/ml
MCF-7: Human breast adenocarcinoma, HepGII: Human hepatocellular 
carcinoma, WISH: Homo sapiens human, P. carotovorum: Pectobacterium 
carotovorum, IC50: Half maximal inhibitory concentration
Table 2: Efficacy of S. marcescens L-asparaginase on cell viability 
relative to its concentration
Concentration 
(µg/ml)
% of cell viability after application of 
S. marcescens L-asparaginase
MCF-7 HepGII WISH
0 100±0.124 100±0.284 100±0.002
6.25 81.122±0.077 80.607±0.189 100.541±0.002
12.5 59.777±0.099 60.846±0.068 99.879±0.006
25 50.805±0.105 49.329±0.074 93.213±0.003
50 45.372±0.058 38.993±0.094 81.802±0.015
100 46.135±0.037 7.532±0.066 64.865±0.004
IC50 26 μg/ml 25 μg/ml 100 μg/ml
S. marcescens: Serratia marcescens, MCF-7: Human breast adenocarcinoma, 
HepGII: Human hepatocellular carcinoma, WISH: Homo sapiens human
Fig. 8: Sodium dodecyl sulfate polyacrylamide gel electrophoreses 
of purified L-asparaginase enzyme from Serratia marcescens 
isolate. Lane 1: Protein marker (10–260 KDa, Thermo Fischer 
Scientific), 2: Ammonium sulfate precipitation, 3: Diethylamino 
ethyl cellulose purification, and 4: Sephadex purification
Fig. 7: L-asparaginase activity and specific activities 
(U/ml) produced by Pectobacterium carotovorum and 
Serratia marcescens isolates before and after optimization
Fig. 9: Photomicrographs of morphological changes for human 
breast adenocarcinoma (MCF-7), human hepatocellular 
carcinoma (HepGII), homo sapiens human cells in response 
to L-asparaginase extracted from Serratia marcescens and 
Pectobacterium carotovorum at ×40 10 magnification microscopy. 
(a, d, and g) MCF-7, HepGII, and WISH cells (control); and 
(b, e, and H): MCF-7, HepGII, and WISH cells treated with 
L-asparaginase from S. marcescens, respectively. (c, f, and i) 
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